Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Undiagnosed Diseases Network, |
RCV000787961 | SCV000926984 | uncertain significance | GP130-deficient hyper-IgE syndrome | 2019-01-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002535763 | SCV003313070 | uncertain significance | not provided | 2022-09-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 12, but is expected to preserve the integrity of the reading-frame (PMID: 33771552). ClinVar contains an entry for this variant (Variation ID: 636253). This variant has been observed in individual(s) with hyper-IgE syndrome (PMID: 33771552). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 12 of the IL6ST gene. It does not directly change the encoded amino acid sequence of the IL6ST protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. |
OMIM | RCV001838639 | SCV002098413 | pathogenic | Hyper-IgE recurrent infection syndrome 4, autosomal recessive | 2023-10-05 | no assertion criteria provided | literature only |